A recent report published by The Business Research Company on Monoclonal Antibodies Market provides
in-depth analysis of segments and sub-segments in the global as well as
regional.
The global monoclonal antibodies (mabs) market was
valued at about $135.38 billion in 2018 and is expected to grow to $212.64
billion at a CAGR of 12.0% through 2022.
The monoclonal antibodies (MABS) market consists of
sales of monoclonal antibodies and related services. Monoclonal antibodies are
used to enhance and suppress immune response in various medical conditions and
to treat various diseases such as cancer, cardiovascular and cerebrovascular
diseases.
View complete Report: https://www.thebusinessresearchcompany.com/report/monoclonal-antibodies-mabs-global-market-report
Major players in the market are Johnson & Johnson,
Merck, AbbVie, Amgen, Glaxosmithkline plc
Alternative treatment methods and natural remedies
are increasingly becoming popular globally and this is expected to have a
negative impact on the revenues of monoclonal antibody drugs market. Treatments
in the fields of homeopathy, Ayurveda, yoga, acupuncture, sujok therapy are
gaining popularity and slowly replacing some traditional hospital practices.
The Food and Drug Administration (FDA) is a federal
agency of the United States Department of Health and Human Services, in the USA
regulating the monoclonal antibodies and pharmaceutical drugs market.
Increasing product launches and regulatory support for the treatment of rare
diseases by USFDA is expected to support the monoclonal antibody therapeutics market
growth.
1. Executive Summary
2. Monoclonal Antibodies Market
Characteristics
3. Monoclonal Antibodies Market
Size And Growth
4. Monoclonal Antibodies Market
Segmentation
5. Monoclonal Antibodies Market
Regional And Country Analysis
6. Asia-Pacific Monoclonal
Antibodies Market
7. China Monoclonal Antibodies
Market
8. India Monoclonal Antibodies
Market
9. Japan Monoclonal Antibodies
Market
10. Australia Monoclonal
Antibodies Market
11. Indonesia Monoclonal
Antibodies Market
12. South Korea Monoclonal
Antibodies Market
About The Business Research Company:
The Business Research Company is
a Business Intelligence Company which excels in company, market and consumer
research. It has offices in the UK, the US and India and a network of trained
researchers in 15 countries globally.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
